Serum levels of BAFF for assessing the disease activity of Takayasu arteritis

Clinical and Experimental Rheumatology

Volumn 28, Issue 1 SUPPL. 57, 2010, Pages

  Nishino, Yuichiro ^a   Tamai, Mami ^b   Kawakami, Atsushi ^b   Koga, Tomohiro ^a   Makiyama, Junya ^a   Maeda, Yumi ^a   Jiuchi, Yuka ^a   Miyashita, Taichiro ^c   Izumi, Yasumori ^a   Eguchi, Katsumi ^b   Migita, Kiyoshi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NONE

Author keywords

Acute phase reactants; B cell activating factor belonging to TNF family; Takayasu arteritis

Indexed keywords

B CELL ACTIVATING FACTOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; METHOTREXATE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; TNFSF13B PROTEIN, HUMAN;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; AORTIC ARCH SYNDROME; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; YOUNG ADULT; B LYMPHOCYTE; BLOOD; DISEASE COURSE; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ACUTE-PHASE PROTEINS; ADULT; AGED; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TAKAYASU ARTERITIS; YOUNG ADULT;

EID: 77954578136     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. NUMANO F, OKAWARA M, INOMATA H, KOBAYASHI Y: Takayasu's arteritis. Lancet 2000; 356: 1023-5.
2. WEYAND CM, GORONZY JJ: Medium- and large-vessel vasculitis. N Engl J Med 2003; 349: 160-9.
3. HOTCHI M: Pathological studies on Takayasu's arteritis. Heart Vessels Suppl 1992; 7: 11-7.
4. KUMAR CHAUHAN S, KUMAR TRIPATHY N, SINHA N, SINGH M, NITYANAND S: Cellular and humoral immune responses to myobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol 2004; 138: 547-53.
5. NORIS M: Pathogenesis of Takayasu's arteritis. J Nephrol 2001; 14: 506-13.
6. MACKAY F, SCHNEIDER P, RENNERT P, BROWNING J: BAFF and April: a tutorial on B cell survival. Annu Rev Immunol 2003; 21: 231-64.
7. SALVARANI C, CANTINI F, BOIARDI L, HUNDER GG: Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003; 21: S23-8.
8. KERR GS, HALLAHAN CW, GIORDANO J, LEAVITT RY, FAUCI AS, ROTTEM M et al.: Takayasu's arteritis. Ann Intern Med 1994; 120: 919-29.
9. COCA A, ANOLIK JH: Targeted biologic approaches to the treatment of systemic vasculitis. Clin Rev Allergy Immunol 2008; 35: 79-87.
10. AREND WP, MICHEL BA, BLOCH DA, HUNDER GG, CALABRESE LH, EDWORTHY SM et al.: The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis Rheum 1990; 33: 1129-34.
11. VANOLI M, DAINA E, SALVARANI C, SABBADINI MG, ROSSI C, BACCHIANI G et al.: Takayasu's arteritis. A study of 104 Italian patients. Arthritis Rheum 2005; 53: 100-7.
12. OHATA J, ZVAIFLER NJ, NISHIO M, BOYLE DL, KALLED SL, CARSON DA et al.: Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 2005; 174: 864-70.
13. SCAPINI P, BAZZONI F, CASSATELLA MA: Regulation of B-cell activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol Lett 2008; 116: 1-6.
14. HAMZAOUI K, HOUMAN H, BEN DHIFALLAH I, KAMOUN M, HAMAZAOUI A: Serum BAFF levels and skin mRNA expression in patients with Behçet's disease. Clin Exp Rheumatol 2008; 26 (Suppl. 50): S64-71.
15. MEVORACH D, LEIBOWITZ G, BREZIS M, RAZ E: Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methetrxate. Ann Rheum Dis 1992; 51: 904-5.
16. PIPITONE N, VERSARI A, SALVARANI C: Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 2008; 47: 403-8.
17. RAMANUJAM M, DAVIDSONA: BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol Rev 2008; 223: 156-74.